Irie RF - Search Results

1

A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patients.

Morioka N, Kikumoto Y, Hoon DS, Morton DL, Irie RF. Morioka N, et al. Among authors: irie rf. J Immunol. 1994 Dec 15;153(12):5650-8. J Immunol. 1994. PMID: 7527447

2

Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.

Hoon DS, Banez M, Okun E, Morton DL, Irie RF. Hoon DS, et al. Among authors: irie rf. Cancer Res. 1991 Apr 15;51(8):2002-8. Cancer Res. 1991. PMID: 1901239

3

Active specific immunotherapy in malignant melanoma.

Morton DL, Foshag LJ, Nizze JA, Gupta RK, Famatiga E, Hoon DS, Irie RF. Morton DL, et al. Among authors: irie rf. Semin Surg Oncol. 1989;5(6):420-5. doi: 10.1002/ssu.2980050608. Semin Surg Oncol. 1989. PMID: 2531908 Review.

4

Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2.

Hoon DS, Irie RF, Cochran AJ. Hoon DS, et al. Among authors: irie rf. Cell Immunol. 1988 Feb;111(2):410-9. doi: 10.1016/0008-8749(88)90104-9. Cell Immunol. 1988. PMID: 3123073

5

Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequence.

Morioka N, Kikumoto Y, Hoon DS, Morton DL, Irie RF. Morioka N, et al. Among authors: irie rf. Mol Immunol. 1995 Jun;32(8):573-81. doi: 10.1016/0161-5890(95)00020-f. Mol Immunol. 1995. PMID: 7541891

6

Human monoclonal antibody identified an immunoreactive tetrapeptide sequence (Lys-Tyr-Gln-Ile) in M(r) 43,000 protein of human melanoma.

Oka T, Kikumoto Y, Itakura K, Morton DL, Irie RF. Oka T, et al. Among authors: irie rf. Cancer Res. 1994 Jul 1;54(13):3511-5. Cancer Res. 1994. PMID: 8012974

7

Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients.

Takahashi T, Irie RF, Morton DL, Hoon DS. Takahashi T, et al. Among authors: irie rf. Cell Immunol. 1997 Jun 15;178(2):162-71. doi: 10.1006/cimm.1997.1126. Cell Immunol. 1997. PMID: 9225007

8

Augmentation of IgM antibody to gp43 tumor-associated antigen peptide by melanoma cell vaccine.

Takahashi T, Conforti A, Kikumoto Y, Hoon DS, Morton DL, Irie RF. Takahashi T, et al. Among authors: irie rf. J Clin Immunol. 1998 Jul;18(4):299-305. doi: 10.1023/a:1027342024618. J Clin Immunol. 1998. PMID: 9710747

9

707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.

Takahashi T, Irie RF, Nishinaka Y, Hoon DS. Takahashi T, et al. Among authors: irie rf. Clin Cancer Res. 1997 Aug;3(8):1363-70. Clin Cancer Res. 1997. PMID: 9815820

10

Cytotoxic T lymphocytes that recognize decameric peptide sequences of retinoblastoma binding protein 1 (RBP-1) associated with human breast cancer.

Takahashi T, Cao J, Hoon DS, Irie RF. Takahashi T, et al. Among authors: irie rf. Br J Cancer. 1999 Sep;81(2):342-9. doi: 10.1038/sj.bjc.6690698. Br J Cancer. 1999. PMID: 10496363 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters